AMETEK, Inc.
In the published model solve dated 2026-Q2, anchored at $236.25, AMETEK, Inc. (AME) is priced for +24.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• AMETEK converts about 26.2% of roughly $7.6 billion of revenue into operating profit, a share only one company in its instruments cohort beats, and it does so across three quite different lines: process and analytical instruments at about 47% of revenue, aerospace and power at about 30%, and automation and engineered solutions at about 24%. • The risk is the price rather than the business: at about 31 times operating profit, the shares need today's economics repeated for roughly five and a hal
Is AME overvalued? See what's priced in →
1,116 institutional managers reported holding AME in 13F filings for the quarter ended 2026-03-31. Together they hold about 85% of the company; the top 10 hold 38%. 115 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 3.5M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AME has cut its share count 0.8% over the past five years, spending $1.04B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 9 years straight; the current rate is $0.56 a share annually. Cash returned over the past three years: $737.18M in dividends and $695.31M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at AME over the trailing three years. Absence is a fact about the company, not a signal. 18 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AME's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | +0.1% | -5.4% |
| 2023-11-01 | +1.6% | +12.8% |
| 2024-02-23 | +1.3% | -0.4% |
| 2024-05-03 | -4.3% | -0.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AME's latest 8-K filings: 2026-08-26 (items 8.01, 9.01); 2026-08-11 (items 8.01); 2026-08-04 (items 2.02, 9.01); 2026-06-12 (items 1.01, 2.03, 9.01); 2026-05-26 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.